Myriam Aouadi
About Myriam Aouadi
Myriam Aouadi is the Associate Director of Clinical Trial Management for the Thoracic Program at Novocure in Root, Lucerne, Switzerland, with extensive experience in managing clinical trials across various therapeutic areas and regions.
Company
Myriam Aouadi is currently working at Novocure. She holds the position of Associate Director Clinical Trial Management - Thoracic Program. Novocure is headquartered in Root, Lucerne, Switzerland. The company focuses on providing treatment options for various cancers, specializing in innovative therapeutic approaches.
Title
Myriam Aouadi is the Associate Director of Clinical Trial Management for the Thoracic Program at Novocure. In this role, she oversees the management of clinical studies and leads trial management teams, focusing specifically on thoracic therapeutic areas.
Education and Expertise
Myriam Aouadi studied at Paris-Sud University (Paris XI), earning a Higher Graduate Degree in Sciences, Biotechnologies, and Health from the Faculty of Sciences 'ORSAY,' between 2002 and 2005. She also completed a Clinical Research Diploma from CLINACT in 2006. Her educational background provides a solid foundation in the scientific and clinical aspects of her work.
Professional Background
Myriam Aouadi has an extensive career in clinical trial management, with roles at several major pharmaceutical companies, including Pfizer, GSK, Amgen, and AstraZeneca. Her career began in the Paris region in France and extended to significant geographical regions such as Basel, Lucerne, and Zürich in Switzerland. Her diverse geographical experience includes managing clinical trials in various therapeutic areas, such as Cell & Gene Therapy, Hematology, and Thoracic programs.
Achievements
Throughout her career, Myriam Aouadi has transitioned from clinical trial leadership roles to strategic positions focused on global portfolio delivery. At Novartis, she held multiple roles, including Global Associate Director Portfolio Delivery - Cell & Gene Therapy, demonstrating her versatility and strategic management capabilities. She has also been involved in business development initiatives, particularly at Phoenix Clinical Research, showcasing her ability to balance operational and strategic responsibilities.